Navigation Links
Drug improves brain function in condition that leads to Alzheimer's
Date:7/20/2011

An existing anti-seizure drug improves memory and brain function in adults with a form of cognitive impairment that often leads to full-blown Alzheimer's disease, a Johns Hopkins University study has found.

The findings raise the possibility that doctors will someday be able to use the drug, levetiracetam, already approved for use in epilepsy patients, to slow the abnormal loss of brain function in some aging patients before their condition becomes Alzheimer's. The researchers emphasize, however, that more studies are necessary before any such recommendation can be made to doctors and patients.

The effects seen in the study "could be like taking your foot off the accelerator or tapping the brakes, and possibly could slow the progression on that path [to Alzheimer's]," said principal investigator and neuroscientist Michela Gallagher. "We need further clinical studies with longer exposure to the drug to, first of all, make sure with rigorous evaluation that the drug is effective in the longer term and, equally important, that it does no harm."

The new study, presented July 20 at the International Congress on Alzheimer's Disease in Paris, also shows that excess brain activity in patients with a condition known as amnestic mild cognitive impairment, or aMCI, contributes to brain dysfunction that underlies memory loss. Previously, it had been thought that this hyperactivity was the brain's attempt to "make up" for weakness in its ability to form new memories.

The clinical study, funded by the National Institutes of Health, tested 34 participants, some healthy older adults and others with aMCI, meaning that they had memory difficulties greater than would be expected at their age. Each person participated in a sequence of two treatment phases lasting two weeks each. Patients received a low dose of levetiracetam during one phase and a placebo during the other.

After each treatment phase, the researchers evaluated subjects' m
'/>"/>

Contact: Lisa DeNike
Lde@jhu.edu
443-287-9960
Johns Hopkins University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. For Some Prostate Cancer Patients, Combo Treatment Improves Survival
2. Arthroscopic treatment of common hip problem improves range of motion
3. Medicaid Coverage Substantially Improves Access to Care: Study
4. Endosonography followed by surgical staging improves quality of life, according to ASTER study
5. Medicaid increases use of health care, decreases financial strain, improves health
6. PACS improves radiologists use of clinical decision support systems
7. Extended sleep improves the athletic performance of collegiate basketball players
8. CT angiography improves detection of heart disease in African-Americans
9. Life Expectancy Improves for Type 1 Diabetics
10. Innovative duct tape strategy saves hospitals time, money; improves infection prevention
11. Study shows pine bark naturally improves heart function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Join Luz Delia Gerber and Abbi Ferrin as ... begins with understanding how the body actually works. A state of mindfulness allows one ... receive tips on how to forge this new relationship with their bodies. , Abi ...
(Date:7/29/2015)... ... July 29, 2015 , ... Ticket Down is a reliable source ... Brazil vs. USA . , The international soccer schedule of matches played on ... now on September 8th, one of the world’s greatest teams, Brazil, will travel to ...
(Date:7/29/2015)... ... July 29, 2015 , ... The NCCA re-accredited the ... expiring November 30, 2019, during its recent meeting. , The Commission received renewal ... program’s compliance with the NCCA’s Standards for the Accreditation of Certification Programs. ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... testing regulations imposed by the FDA for nicotine laced liquid products. Their report ... cigarettes have raised considerably. E-Cigarettes are particularly troublesome to addiction professionals as many ...
(Date:7/29/2015)... ... 2015 , ... With a new community program in the ... Support Services and announced a new charity campaign to raise funds to support ... workshops and educational programs at no charge. Scott Campbell Agency initiates this ...
Breaking Medicine News(10 mins):Health News:Pampering and Empowerment Abound at Final Event in Luz Delia Gerber’s Book Unveiling 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3
... Adenotonsillectomy is a common procedure in children , even ... with milder symptoms.// A new study suggests there are ... in children with mild throat infections. ,Researchers examined ... infections or enlarged tonsils and adenoids. Half of the ...
... of risk factors known as metabolic syndrome is able ... factors. // ,Metabolic syndrome has been shown ... heart disease. Metabolic syndrome includes looking at factors such ... two different definitions including one by the National Cholesterol ...
... who were treated for depression responded better if they ... blood.// ,An increasing amount of research is looking ... the specifics have not been understood. Researchers conducted a ... and the treatment of depression. ,The study included ...
... Currently, lung cancer is the leading cause of cancer death ... shows women // have double the risk of developing lung ... York studied nearly 3,000 men and women ages 40 and ... -- such as age, gender and number of years smoking ...
... activity of adults with asthma. Knowing if asthma patients ... help health professionals in designing fitness programs for asthma ... and Prevention conducted a study to look at the ... included data on 165,123 participants.Researchers say about 30 percent ...
... advanced stage is key to survival of patients say researchers ... scan can detect early lung cancer, researchers wanted to determine ... by researchers who wanted to look at the cost-effectiveness of ... was part of the Early Lung Cancer Action Project (ELCAP) ...
Cached Medicine News:
(Date:7/29/2015)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), today announced ... June 30, 2015. "We are impressed with ... Mihael H. Polymeropoulos M.D., Vanda,s President and CEO, "further ... our products set the stage for the next level ... , Total net product sales for the second ...
(Date:7/29/2015)... Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a ... medicine, today announced that it will release second quarter ... after the close of the U.S. financial markets. The ... Monday, August 10, 2015 at 4:30 p.m. Eastern / ... developments. For both "listen-only" participants and those ...
(Date:7/29/2015)...  Depomed, Inc. (NASDAQ: DEPO ) ("Depomed" or ... Directors, after careful consideration and with the assistance ... unanimously rejected the purported revised, highly conditional, unsolicited ... HZNP ) ("Horizon") to acquire all of ... transaction (the "July 21 Proposal"). ...
Breaking Medicine Technology:Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 6Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 7Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 8Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 9Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 10Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 11Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 12Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 13Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 14Asterias Biotherapeutics to Report Second Quarter Results on August 10, 2015 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9
... (Nasdaq: MYL ) today announced that its ... mg and 200 mg, under a previously announced settlement ... first company to have filed a substantially complete ANDA ... was awarded 180 days of marketing exclusivity.   ...
... Feb. 15, 2011 Lexicon Pharmaceuticals, Inc. ... on discovering and developing breakthrough treatments for human disease, ... financial results on Thursday, February 24, 2011 before the ... call and webcast to discuss clinical development progress and ...
Cached Medicine Technology:Lexicon to Report Fourth Quarter and Year End 2010 Financial Results on February 24, 2011 2
Stent delivery with extra rail support...
... The eNclose Anastomosis Assist ... to obviate the need ... the aorta. The enclose ... surgeon with a stable, ...
15mm Open Blades, Thumb Screw Control; in Titanium....
5mm Gently Curved Wing Span, With Centering Pin, Low Profile; in stainless steel....
Medicine Products: